Interim Report 2026
Filed with HKEX · Stock code 1501 · · 69 pages · English
Summary by 6ix AI
The report highlights a significant increase in revenue and gross profit compared to the same period in the previous year, driven by strategic acquisitions and enhanced sales of interventional medical devices. The company reported a profit for the period, although earnings per share saw a slight decline. Additionally, the board has decided not to declare any interim dividend for this reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Shanghai INT Medical Instruments Co., Ltd. on 6ix
Earlier from Shanghai INT Medical Instruments
- Discloseable transaction in relation to the further acquisition of equity interests in the target company
- Inside information registration for pre-listing tutoring regarding the proposed Issuance of a shares
Later from Shanghai INT Medical Instruments
- List of directors and their roles and functions
- Poll results of 2026 first extraordinary general meeting held on 24 September 2026; and (2) change of composition of the board and board committees
- Articles of Association
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
- (1) Proposed Issuance of a shares and related matters; (2) proposed adoption of the articles of association applicable upon the listing of a shares; (3) proposed adoption of the governance policies applicable upon the listing of a shares; and (4) amendments to the h share award and trust scheme
Follow Shanghai INT Medical Instruments into a list and get an email when it puts out news.
Follow Shanghai INT Medical Instruments